Summary
The structure of the Gene 33 protein suggests that it plays a role in intracellular signaling and Gene 33 is induced by many mitogenic and stressful stimuli. Previously, we found that Gene 33 expression is significantly induced by retinoic acid (RA), insulin and synergistically by both in a liver-derived cell line. In the present study, we investigated the basal expression and regulation of Gene 33 in multiple human breast cancer cell lines. These cell lines expressed different levels of Gene 33 protein, but Gene 33 protein was not regulated by RA or insulin, either alone, or in combination. However, epidermal growth factor (EGF) induced Gene 33 expression in SK-BR-3 cells and this induction was inhibited by co-treatment with RA. There was a strong correlation between endogenous basal Gene 33 expression and doubling time. Exogenous expression of Gene 33 in MCF-7 cells did not affect cell cycle distribution, but inhibited apoptosis and specifically increased the level of Poly(ADP-ribose) Polymerase (PARP-1) protein. This suggests that Gene 33 promotes breast cancer cell growth by an anti-apoptotic rather than a mitogenic effect, possibly involving up-regulation of PARP-1.
Article PDF
Similar content being viewed by others
References
MH Tindal KL Lee KR Isham C Cadilla FT Kenney (1988) ArticleTitleStructure of a multihormonally regulated rat gene Gene 71 413–420 Occurrence Handle10.1016/0378-1119(88)90058-3 Occurrence Handle1:CAS:528:DyaL1MXkvFWntbk%3D Occurrence Handle3224831
JL Messina (1994) Regulation of gene 33 expression by insulin B Draznin D Leroith (Eds) Molecular Biology of Diabetes. Part II. Insulin Actions, Effects on Gene Expression and Regulation and Glucose Transport, Chap 130 Totowa NJ 263–281
PO Hackel M Gishizky A Ullrich (2001) ArticleTitleMig-6 is a negative regulator of the epidermal growth factor receptor signal Biol Chem 382 1649–1662 Occurrence Handle10.1515/BC.2001.200 Occurrence Handle1:CAS:528:DC%2BD38XisVKhsL0%3D Occurrence Handle11843178
L Fiorentino C Pertica M Fiorini C Talora M Crescenzi L Castellani S Alema P Benedetti O Segatto (2000) ArticleTitleInhibition of ErbB-2 mitogenic and transforming activity by RALT, a mitogen-induced signal transducer which binds to the ErbB-2 kinase domain Mol Cell Biol 20 7735–7750 Occurrence Handle10.1128/MCB.20.20.7735-7750.2000 Occurrence Handle1:CAS:528:DC%2BD3cXnt1aitLk%3D Occurrence Handle11003669
M Fiorini C Ballaro G Sala G Falcone S Alema O Segatto (2002) ArticleTitleExpression of RALT, a feedback inhibitor of ErbB receptors, is subjected to an integrated transcriptional and post-translational control Oncogene 21 6530–6539 Occurrence Handle10.1038/sj.onc.1205823 Occurrence Handle1:CAS:528:DC%2BD38XmvVOqsLc%3D Occurrence Handle12226756
S Anastasi L Fiorentino M Fiorini R Fraioli G Sala L Castellani S Alema M Alimandi O Segatto (2003) ArticleTitleFeedback inhibition by RALT controls signal output by the ErbB network Oncogene 22 4221–4234 Occurrence Handle10.1038/sj.onc.1206516 Occurrence Handle1:CAS:528:DC%2BD3sXkvFSkuro%3D Occurrence Handle12833145
A Makkinje DA Quinn A Chen CL Cadilla T Force JV Bonventre JM Kyriakis (2000) ArticleTitleGene 33/Mig-6, a transcriptionally inducible adapter protein that binds GTP-Cdc42 and activates SAPK/JNK. A potential marker transcript for chronic pathologic conditions, such as diabetic nephropathy. Possible role in the response to persistent stress J Biol Chem 275 17838–17847 Occurrence Handle10.1074/jbc.M909735199 Occurrence Handle1:CAS:528:DC%2BD3cXktFaktbc%3D Occurrence Handle10749885
T Tsunoda J Inokuchi I Baba K Okumura S Naito T Sasazuki S Shirasawa (2002) ArticleTitleA novel mechanism of nuclear factor kappa B activation through the binding between inhibitor of nuclear factor-kappa B alpha and the processed NH(2)-terminal region of Mig-6 Cancer Res 62 5668–5671 Occurrence Handle1:CAS:528:DC%2BD38XotFyksLc%3D Occurrence Handle12384522
LM De Luca (1991) ArticleTitleRetinoids and their receptors in differentiation, embryogenesis, and neoplasia FASEB J 5 2924–2933 Occurrence Handle1:CAS:528:DyaK38XhvVKqtA%3D%3D Occurrence Handle1661245
Q Yang T Sakurai K Kakudo (2002) ArticleTitleRetinoid, retinoic acid receptor beta and breast cancer Breast Cancer Res Treat 76 167–173 Occurrence Handle10.1023/A:1020576606004 Occurrence Handle1:CAS:528:DC%2BD38XnvVSgtL0%3D Occurrence Handle12452454
V Papa A Belfiore (1996) ArticleTitleInsulin receptors in breast cancer: biological and clinical role J Endocrinol Invest 19 324–333 Occurrence Handle1:STN:280:BymA1cbgtFU%3D Occurrence Handle8796343
A Belfiore L Frittitta A Costantino F Frasca G Pandini L Sciacca ID Goldfine R Vigneri (1996) ArticleTitleInsulin receptors in breast cancer Ann NY Acad Sci 784 173–188 Occurrence Handle1:CAS:528:DyaK28Xkt1ejs7Y%3D Occurrence Handle8651567
L Wideroff G Gridley L Mellemkjaer WH Chow M Linet S Keehn K Borch-Johnsen JH Olsen (1997) ArticleTitleCancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark J Natl Cancer Inst 89 1360–1365 Occurrence Handle10.1093/jnci/89.18.1360 Occurrence Handle1:STN:280:ByiH2M3ivFY%3D
E Weiderpass G Gridley I Persson O Nyren A Ekbom HO Adami (1997) ArticleTitleRisk of endometrial and breast cancer in patients with diabetes mellitus Int J Cancer 71 360–363 Occurrence Handle10.1002/(SICI)1097-0215(19970502)71:3<360::AID-IJC9>3.0.CO;2-W Occurrence Handle1:STN:280:ByiB1cvksFA%3D Occurrence Handle9139868
BA Stoll (1996) ArticleTitleNutrition and breast cancer risk: can an effect via insulin resistance be demonstrated? Breast Cancer Res Treat 38 239–246 Occurrence Handle1:STN:280:BymA38flslA%3D Occurrence Handle8739075
TA Kent JL Messina RS Weinstock JP Stein (1994) ArticleTitleSynergistic induction of gene 33 expression by retinoic acid and insulin Endocrinology 134 2237–2244 Occurrence Handle10.1210/en.134.5.2237 Occurrence Handle1:CAS:528:DyaK2cXivFSntbo%3D Occurrence Handle8156927
AB Keeton J Xu jl franklin JL Messina (2004) ArticleTitleRegulation of Gene33 expression by insulin requires MEK-ERK activation Biochim Biophys Acta 1679 248–255 Occurrence Handle1:CAS:528:DC%2BD2cXnsFGmt7k%3D Occurrence Handle15358516
DJ Buchsbaum T Zhou WE Grizzle PG Oliver CJ Hammond M Carpenter AF LoBuglio (2003) ArticleTitleAntitumour efficiency of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model Clin Cancer Res 9 3731–3741 Occurrence Handle1:CAS:528:DC%2BD3sXosVOksrk%3D Occurrence Handle14506165
JA Low MD Johnson EA Bone RB Dickson (1996) ArticleTitleThe matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumour growth but not ascites formation in nude mice Clin Cancer Res 2 1207–1214 Occurrence Handle1:CAS:528:DyaK28XksFequrg%3D Occurrence Handle9816289
F Leonessa D Green T Licht A Wright K Wingate-Legette J Lippman MM Gottesman R Clarke (1996) ArticleTitleMDA435/LCC6 and MDA435/LCC6MDR1: ascites models of human breast cancer Br J Cancer 73 154–161 Occurrence Handle1:STN:280:BymC2M%2FhtlI%3D Occurrence Handle8546900
AB Keeton MO Amsler DY Venable JL Messina (2002) ArticleTitleInsulin signal transduction pathways and insulin-induced gene expression J Biol Chem 277 48565–48573 Occurrence Handle1:CAS:528:DC%2BD38Xptlegt7Y%3D Occurrence Handle12364332
S Ji R Guan SJ Frank JL Messina (1999) ArticleTitleInsulin inhibits growth hormone signaling via the growth hormone receptor/JAK2/STAT5B pathway J Biol Chem 274 13434–13442 Occurrence Handle1:CAS:528:DyaK1MXjtFOltLg%3D Occurrence Handle10224108
Y Ma P Wang JF Kuebler IH Chaudry JL Messina (2003) ArticleTitleHemorrhage induces the rapid development of hepatic insulin resistance Am J Physiol Gastrointest Liver Physiol 284 G107–G115 Occurrence Handle1:CAS:528:DC%2BD3sXntVSntQ%3D%3D Occurrence Handle12388175
K Wosikowski D Schuurhuis GJ Kops M Saceda SE Bates (1997) ArticleTitleAltered gene expression in drug-resistant human breast cancer cells Clin Cancer Res 3 2405–2414 Occurrence Handle1:CAS:528:DyaK1cXisV2qtg%3D%3D Occurrence Handle9815641
X Zhang T Zhu Y Chen HC Mertani KO Lee PE Lobie (2003) ArticleTitleHuman growth hormone-regulated HOXA1 is a human mammary epithelial oncogene J Biol Chem 278 7580–7590 Occurrence Handle1:CAS:528:DC%2BD3sXhsVKitbk%3D Occurrence Handle12482855
PR Walker J Kwast-Welfeld H Gourdeau J Leblanc W Neugebauer M Sikorska (1993) ArticleTitleRelationship between apoptosis and the cell cycle in lymphocytes: roles of protein kinase C, tyrosine phosphorylation, and AP1 Exp Cell Res 207 142–151 Occurrence Handle1:CAS:528:DyaK3sXltFGgs7w%3D Occurrence Handle8319766
RS Weinstock CA Manning JL Messina (1992) ArticleTitleThe regulation of p33 gene expression by insulin and calcium ionophores Endocrinology 130 616–624 Occurrence Handle1:CAS:528:DyaK38Xht1Wgtb0%3D Occurrence Handle1733711
G Pandini R Vigneri A Costantino F Frasca A Ippolito Y Fujita-Yamaguchi K Siddle ID Goldfine A Belfiore (1999) ArticleTitleInsulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling Clin Cancer Res 5 1935–1944 Occurrence Handle1:CAS:528:DyaK1MXltVCqtL8%3D Occurrence Handle10430101
SM Schneider M Offterdinger H Huber TW Grunt (2000) ArticleTitleActivation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells Cancer Res 60 5479–5487 Occurrence Handle1:CAS:528:DC%2BD3cXns1ehtrg%3D Occurrence Handle11034091
K Okamoto F Andreola MV Chiantore RL Dedrick LM De Luca (2000) ArticleTitleDifferences in uptake and metabolism of retinoic acid between estrogen receptor-positive and -negative human breast cancer cells Cancer Chemother Pharmacol 46 128–134 Occurrence Handle1:CAS:528:DC%2BD3cXltFKhs7g%3D Occurrence Handle10972482
T Grunt E Dittrich M Offterdinger SM Schneider C Dittrich Huber (1998) ArticleTitleEffects of retinoic acid and fenretinide on the c-erbB-2 expression, growth and cisplatin sensitivity of breast cancer cells Br J Cancer 78 79–87 Occurrence Handle1:CAS:528:DyaK1cXksVyntL4%3D Occurrence Handle9662255
P Fitzgerald M Teng RA Chandraratna RA Heyman EA Allegretto (1997) ArticleTitleRetinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status Cancer Res 57 2642–2650 Occurrence Handle1:STN:280:ByiA2cbgs1M%3D Occurrence Handle9205071
S Ortega M Malumbres M Barbacid (2002) ArticleTitleCyclin D-dependent kinases, INK4 inhibitors and cancer Biochim Biophys Acta 1602 73–87 Occurrence Handle1:CAS:528:DC%2BD38XktVKgu7o%3D Occurrence Handle11960696
EA Musgrove R Hui KJ Sweeney CK Watts RL Sutherland (1996) ArticleTitleCyclins and breast cancer J Mammary Gland Biol Neoplasia 1 153–162 Occurrence Handle1:STN:280:DC%2BD3czksFOjsw%3D%3D Occurrence Handle10887489
DA Gewirtz (2000) ArticleTitleGrowth arrest and cell death in the breast tumour cell in response to ionizing radiation and chemotherapeutic agents which induce DNA damage Breast Cancer Res Treat 62 223–235 Occurrence Handle1:CAS:528:DC%2BD3cXnvV2qur0%3D Occurrence Handle11072787
JC Reed (1998) ArticleTitleBcl-2 family proteins Oncogene 17 3225–3236 Occurrence Handle9916985
A Gross JM McDonnell SJ Korsmeyer (1999) ArticleTitleBCL-2 family members and the mitochondria in apoptosis Genes Dev 13 1899–1911 Occurrence Handle1:CAS:528:DyaK1MXltlGktrg%3D Occurrence Handle10444588
G Nunez MA Benedict Y Hu N Inohara (1998) ArticleTitleCaspases: the proteases of the apoptotic pathway Oncogene 17 3237–3245 Occurrence Handle9916986
LM Mooney KA Al Sakkaf BL Brown PR Dobson (2002) ArticleTitleApoptotic mechanisms in T47D and MCF-7 human breast cancer cells Br J Cancer 87 909–917 Occurrence Handle1:CAS:528:DC%2BD38Xns1Gnt7o%3D Occurrence Handle12373608
PD Burbelo D Drechsel A Hall (1995) ArticleTitleA conserved binding motif defines numerous candidate target proteins for both Cdc42 and Rac GTPases J Biol Chem 270 29071–29074 Occurrence Handle1:CAS:528:DyaK2MXpvVOhtbo%3D Occurrence Handle7493928
R Ren BJ Mayer P Cicchetti D Baltimore (1993) ArticleTitleIdentification of a ten-amino acid proline-rich SH3 binding site Science 259 1157–1161 Occurrence Handle1:CAS:528:DyaK3sXks1Gqs7g%3D Occurrence Handle8438166
AJ Muslin JW Tanner PM Allen AS Shaw (1996) ArticleTitleInteraction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine Cell 84 889–897 Occurrence Handle1:CAS:528:DyaK28XhvFKjsrc%3D Occurrence Handle8601312
T Laar Particlevan T Schouten AJ Eb Particlevan der C Terleth (2001) ArticleTitleInduction of the SAPK activator MIG-6 by the alkylating agent methyl methanesulfonate Mol Carcinog 31 63–67 Occurrence Handle11429782
AC Johnson K-L Lee KR Isham FT Kenney (1988) ArticleTitleGene-specific acquisition of hormonal responsiveness in rat liver during development J Cell Biochem 37 243–253 Occurrence Handle1:CAS:528:DyaL1cXktFOhu74%3D Occurrence Handle2456297
WL Kraus JT Lis (2003) ArticleTitlePARP goes transcription Cell 113 677–683 Occurrence Handle1:CAS:528:DC%2BD3sXkvVekt70%3D Occurrence Handle12809599
A Tulin A Spradling (2003) ArticleTitleChromatin loosening by poly (ADP)-ribose polymerase (PARP) at Drosophila puff loci Science 299 560–562 Occurrence Handle1:CAS:528:DC%2BD3sXlsVarsg%3D%3D Occurrence Handle12543974
A Tulin D Stewart AC Spradling (2002) ArticleTitleThe Drosophila heterochromatic gene encoding poly (ADP-ribose) polymerase (PARP) is required to modulate chromatin structure during development Genes Dev 16 2108–2119 Occurrence Handle1:CAS:528:DC%2BD38Xmtl2hurc%3D Occurrence Handle12183365
GG Poirier G De Murcia J Jongstra-Bilen C Niedergang P Mandel (1982) ArticleTitlePoly (ADP-ribosyl)ation of polynucleosomes causes relaxation of chromatin structure Proc Natl Acad Sci U S A 79 3423–3427 Occurrence Handle1:CAS:528:DyaL38XktlCqsb0%3D Occurrence Handle6808510
G De Murcia A Huletsky D Lamarre A Gaudreau J Pouyet M Daune GG Poirier (1986) ArticleTitleModulation of chromatin superstructure induced by poly (ADP-ribose) synthesis and degradation J Biol Chem 261 7011–7017 Occurrence Handle1:CAS:528:DyaL28XktVansb4%3D Occurrence Handle3084493
MG Anderson KE Scoggin CM Simbulan-Rosenthal JA Steadman (2000) ArticleTitleIdentification of poly (ADP-ribose) polymerase as a transcriptional coactivator of the human T-cell leukemia virus type 1 Tax protein J Virol 74 2169–2177 Occurrence Handle1:CAS:528:DC%2BD3cXhtF2ktrg%3D Occurrence Handle10666246
MN Cervellera A Sala (2000) ArticleTitlePoly(ADP-ribose) polymerase is a B-MYB coactivator J Biol Chem 275 10692–10696 Occurrence Handle1:CAS:528:DC%2BD3cXisFWju74%3D Occurrence Handle10744766
PO Hassa MO Hottiger (2002) ArticleTitleThe functional role of poly (ADP-ribose)polymerase 1 as novel coactivator of NF-kappa B in inflammatory disorders Cell Mol Life Sci 59 1534–1553 Occurrence Handle1:CAS:528:DC%2BD38Xotlahurc%3D Occurrence Handle12440774
T Miyamoto T Kakizawa K Hashizume (1999) ArticleTitleInhibition of nuclear receptor signalling by poly (ADP-ribose) polymerase Mol Cell Biol 19 2644–2649 Occurrence Handle10082530
J Nie S Sakamoto D Song Z Qu K Ota T Taniguchi (1998) ArticleTitleInteraction of Oct-1 and automodification domain of poly(ADP-ribose) synthetase FEBS Lett 424 27–32 Occurrence Handle1:CAS:528:DyaK1cXhsFejurY%3D Occurrence Handle9537509
S Boulton LC Pemberton JK Porteous NJ Curtin RJ Griffin BT Golding BW Durkacz (1995) ArticleTitlePotentiation of temozolomide-induced cytotoxicity: a comparative study of the biological effects of poly (ADP-ribose) polymerase inhibitors Br J Cancer 72 849–856 Occurrence Handle1:CAS:528:DyaK2MXptlKjtL0%3D Occurrence Handle7547230
ML Agarwal A Agarwal WR Taylor ZQ Wang EF Wagner GR Stark (1997) ArticleTitleDefective induction but normal activation and function of p53 in mouse cells lacking poly-ADP-ribose polymerase Oncogene 15 1035–1041 Occurrence Handle1:CAS:528:DyaK2sXmtVKisrs%3D Occurrence Handle9285557
M Malanga JM Pleschke HE Kleczkowska FR Althaus (1998) ArticleTitlePoly (ADP-ribose) binds to specific domains of p53 and alters its DNA binding functions J Biol Chem 273 11839–11843 Occurrence Handle1:CAS:528:DyaK1cXjt1aiurg%3D Occurrence Handle9565608
C Trucco FJ Oliver G De Murcia J Menissier-de Murcia (1998) ArticleTitleDNA repair defect in poly (ADP-ribose) polymerase-deficient cell lines Nucleic Acids Res 26 2644–2649 Occurrence Handle1:CAS:528:DyaK1cXktFalur4%3D Occurrence Handle9592149
DW Nicholson NA Thornberry (1997) ArticleTitleCaspases: killer proteases Trends Biochem Sci 22 299–306 Occurrence Handle1:CAS:528:DyaK2sXlsF2jsbY%3D Occurrence Handle9270303
M Germain EB Affar D D’Amours VM Dixit GS Salvesen GG Poirier (1999) ArticleTitleCleavage of automodified poly (ADP-ribose) polymerase during apoptosis. Evidence for involvement of caspase-7 J Biol Chem 274 28379–28384 Occurrence Handle10.1074/jbc.274.40.28379 Occurrence Handle1:CAS:528:DyaK1MXmsFWgtbw%3D Occurrence Handle10497198
SH Kaufmann S Desnoyers Y Ottaviano NE Davidson GG Poirier (1993) ArticleTitleSpecific proteolytic cleavage of poly (ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis Cancer Res 53 3976–3985 Occurrence Handle1:CAS:528:DyaK3sXmtFKqsro%3D Occurrence Handle8358726
YA Lazebnik SH Kaufmann S Desnoyers GG Poirier WC Earnshaw (1994) ArticleTitleCleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE Nature 371 346–347 Occurrence Handle1:STN:280:ByuA2snoslI%3D Occurrence Handle8090205
RJ Griffin NJ Curtin DR Newell BT Golding BW Durkacz AH Calvert (1995) ArticleTitleThe role of inhibitors of poly (ADP-ribose) polymerase as resistance-modifying agents in cancer therapy Biochimie 77 408–422 Occurrence Handle1:CAS:528:DyaK2MXnsVKjtLo%3D Occurrence Handle7578423
CA Delaney LZ Wang S Kyle AW White AH Calvert NJ Curtin BW Durkacz Z Hostomsky DR Newell (2000) ArticleTitlePotentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly (adenosine diphosphoribose) polymerase inhibitors in a panel of human tumour cell lines Clin Cancer Res 6 2860–2867 Occurrence Handle1:CAS:528:DC%2BD3cXlslentbg%3D Occurrence Handle10914735
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Xu, J., Keeton, A.B., Wu, L. et al. Gene 33 inhibits apoptosis of breast cancer cells and increases poly(ADP-ribose) polymerase expression. Breast Cancer Res Treat 91, 207–215 (2005). https://doi.org/10.1007/s10549-005-1040-1
Issue Date:
DOI: https://doi.org/10.1007/s10549-005-1040-1